Covered recipient · General Payments record
FIONA MARY MALMENDIER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$986.00
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $526.83 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $189.41 | 8 |
| Gilead Sciences, Inc. | $142.13 | 9 |
| Alkermes, Inc. | $58.14 | 3 |
| Indivior Inc. | $49.94 | 2 |
| Orexo US, Inc. | $33.69 | 2 |
| Neurocrine BioSciences, Inc. | $33.06 | 2 |
| Acerta Pharma LLC | $20.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.00 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107581986 | CMS |
| ABBVIE INC. | $28.94 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107581988 | CMS |
| ABBVIE INC. | $21.85 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107581990 | CMS |
| ABBVIE INC. | $13.79 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107581992 | CMS |
| ABBVIE INC. | $19.37 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107581994 | CMS |
| ABBVIE INC. | $16.98 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107581996 | CMS |
| ABBVIE INC. | $29.35 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107581998 | CMS |
| ABBVIE INC. | $30.13 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107582000 | CMS |
| Alkermes, Inc. | $19.18 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120546813 | CMS |
| Alkermes, Inc. | $21.49 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120546815 | CMS |
| Alkermes, Inc. | $17.47 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120546817 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.46 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104482364 | CMS |
| Gilead Sciences, Inc. | $25.62 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668582 | CMS |
| Gilead Sciences, Inc. | $19.59 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668584 | CMS |
| Gilead Sciences, Inc. | $6.40 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668586 | CMS |
| Gilead Sciences, Inc. | $22.20 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668588 | CMS |
| Gilead Sciences, Inc. | $19.85 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668590 | CMS |
| Gilead Sciences, Inc. | $18.91 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668592 | CMS |
| Gilead Sciences, Inc. | $6.59 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668594 | CMS |
| Gilead Sciences, Inc. | $16.27 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668596 | CMS |
| Gilead Sciences, Inc. | $6.70 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133668598 | CMS |
| Indivior Inc. | $24.58 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144561479 | CMS |
| Indivior Inc. | $25.36 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144561481 | CMS |
| Neurocrine Biosciences, Inc. | $13.71 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151008613 | CMS |
| Neurocrine Biosciences, Inc. | $19.35 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150983084 | CMS |
| Orexo US, Inc. | $14.90 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136177756 | CMS |
| Orexo US, Inc. | $18.79 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136177266 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.